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Abstract
Recombinant Bombyx mori nucleopolyhedroviruses (BmNPV) displaying the immunodominant ectodomains of fusion glycoprotein (F)
of Peste des petitis ruminants virus (PPRV) and the hemagglutinin protein (H) of Rinderpest virus (RPV), on the budded virions as well
as the surface of the infected host cells have been constructed. The F and H protein sequences were inserted in-frame within the
amino-terminal region of BmNPV envelope glycoprotein GP64 expressing under the strong viral polyhedrin (polh) promoter. We improved
the recombinant virus selection in BmNPV by incorporating the green fluorescent protein gene (gfp) as selection marker under a separate
promoter within the transfer cassette harboring the desired genes. Following infection of the insect larvae or the host-derived BmN cells with
these recombinant BmNPVs, the expressed GP64 fusion proteins were displayed on the host cell surface and the budded virions. The
antigenic epitopes of the recombinant proteins were properly displayed and the recombinant virus particles induced immune response in
mice against PPRV or RPV.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
Insect cell-based baculovirus expression systems have
been extensively exploited for the large-scale production of
recombinant proteins (Luckow and Summers, 1988; Fraser,
1992; King and Possee, 1992). The most widely adopted
system makes use of the strong, very late promoters of
polyhedrin (polh) or p10 of the baculovirus Autographa
californica multinucleocapsid nucleopolyhedrovirus
(AcMNPV). Next in popularity to the AcMNPV among
baculoviruses is the Bombyx mori nucleopolyhedrovirus
(BmNPV), which provides the additional advantage of mak-
ing use of the insect larvae than the cell lines in culture for
large-scale production of recombinant proteins (Maeda,
1989; Palhan et al., 1995; Sumathy et al., 1996; Sriram et
al., 1997; Sehgal and Gopinathan, 1998; Acharya et al.,
2002). In addition to the successful expression of hundreds
of recombinant proteins, the recent developments in bacu-
lovirus methodology include the surface display of proteins
(Grabherr et al., 2001; Rahman and Gopinathan, 2003a) and
gene delivery vehicles in diverse mammalian cells (Kost
and Condreay, 2002).
AcMNPV was the first baculovirus to be developed as a
vector to display foreign proteins on the virus or host cell
surfaces, where the foreign gene sequence was fused in-
frame with a gene encoding one of the virus membrane
proteins and the hybrid fusion protein was incorporated into
virus particles (Boublik et al., 1995; Grabherr et al., 2001).
We have recently developed a similar eukaryotic cell-sur-
face display system using BmNPV (Rahman and Gopi-
nathan, 2003a).
GP64, a type I transmembrane glycoprotein encoded by
the baculoviruses and comprising an amino-terminal signal
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peptide and a carboxy-proximal transmembrane domain, is
responsible for the virus entry into the host cells and effi-
cient virion budding (Monsma and Blissard, 1995; Rahman
and Gopinathan, 2003b). The virally encoded GP64 protein
gets incorporated into the host cell membrane. During the
budding process, the emerging virus nucleocapsid particles
(budded virions) pick up the protein as the constituent viral
envelope. Since gp64 is essential for the virus infection
process, we introduced a second copy of the gene at the polh
locus of BmNPV for manipulations and to achieve high
levels of expression (Rahman and Gopinathan, 2003a). On
infection, such recombinant viruses with the foreign gene
inserted within the gp64 copy at the polh locus lead to the
synthesis of substantive amounts of the fusion protein that
gets displayed on the surface of the infected cell as well as
the budded virions. The recombinant BmNPVs displaying
foreign protein also maintained their infectivity in different
tissues of the infected larvae.
To express large amounts of foreign antigens, we con-
structed recombinant BmNPVs expressing complex anti-
gens from the members of the Paramyxoviridae family, as
GP64 fusion proteins on the surface of virions and on the
membrane of virally infected cells. The immunogenicity of
peptide epitopes is known to be enhanced by fusion to larger
carrier molecules. Viruses or even virus-like particles that
carry multiple copies of the epitope effectively serve as
candidate subunit vaccines.
Viruses belonging to the Paramyxoviridae family con-
tain two integral membrane glycoproteins, the hemaggluti-
nin (H) or hemagglutinin-neuraminidase protein (HN) and
the fusion protein (F). The H/HN glycoprotein is responsi-
ble for attaching the virion to the target cell, while the F
protein is believed to disrupt the target cell membrane
leading to virus–cell and cell–cell fusions. In this family of
viruses, the two closely related members of the morbillivi-
rus genus Rinderpest virus (RPV) and Peste des petits
ruminants virus (PPRV) are of great economic significance.
RPV affects domestic cattle and buffaloes as well as many
cloven-hoofed animals in the wild. The disease is enzootic
in South Asia and the Near and Middle East (Barrett and
Rossiter, 1999). PPRV, also known as “goat plague” is an
acute, highly contagious viral disease of goat and sheep.
PPRV is widespread across sub-Saharan Africa, the Arabian
Peninsula, and the Indian subcontinent (Roeder and Obi,
1999) and causes high mortality and severe morbidity in
infected animals. The membrane glycoproteins, H/HN or F,
of these viruses together are responsible for protective im-
munity (Yilma et al., 1988; Romero et al., 1994) and thus
are considered as promising candidates for subunit vac-
cines.
The immunogenic properties of recombinant H protein
of RPV in secreted (secH) as well as membrane-bound
forms as extracellular baculovirus particles (rECV-H) have
been previously examined (Naik and Shaila, 1997). The H
protein presented on rECV particles generated virus neu-
tralizing antibodies and helper T cell responses in cattle
(Sinnathamby et al., 2001). More recently, immunodomi-
nant epitopes on RPV-H have been mapped and an epitope
unique to RPV-H and not present on the corresponding
protein of PPRV has been identified (Renukaradhya et al.,
2002). Compared to the H protein, the immunogenic prop-
erties of F have not been studied in any great detail. The
fusion protein is responsible for important biological activ-
ities, such as penetration of the virus into the host cell by
cell fusion, and hemolysis (Scheid and Choppin, 1977). The
PPRV-induced cell fusion and F protein mediated hemoly-
sis were inhibited by the hyperimmune serum against the F
protein (Devireddy et al., 1999). It also gave protection to
rabbits against lapinized rinderpest virus (Devireddy et al.,
1998). There is remarkable sequence homology between
fusion proteins of the paramyxoviruses, indicating their
conserved biological activity (Lamb, 1993).
Here we report the construction of recombinant BmNPVs
expressing antigenic epitopes of F protein from PPRV and
H protein from RPV as GP64 fusions and demonstrate that
the fusions were displayed on the virion surface as well as
the surface of the virus-infected cells. The antigenicity of
the viral antigen as GP64 fusion protein has also been tested
in the mouse model.
Results and discussion
Construction of recombinant viruses
A eukaryotic cell-surface display system with BmNPV
was developed using gp64, the viral gene encoding the
surface glycoprotein GP64 (Rahman and Gopinathan,
2003a). Since gp64 is a single copy gene in BmNPV and is
essential for the virus propagation, all manipulations of
gp64 were undertaken with a second copy of the gene that
was inserted at the polh locus. The functional domains of
gp64 mapped in AcMNPV (Monsma and Blissard, 1995)
are also conserved in BmNPV. We made use of a unique
BamHI site at 300 nt from 1 ATG of the gp64-ORF to
express the heterologous genes [encoding part of PPRV
fusion protein (F) or the RPV hemagglutinin protein (H)] as
GP64-fusion proteins, while retaining the functional do-
mains of GP64 intact (Fig. 1). The suitability of BmNPV
GP64 to direct the incorporation of fusion protein into the
baculovirus particle was previously established by using
GFP as a model protein (Rahman and Gopinathan, 2003a).
Here we have generated recombinant BmNPVs displaying
truncated fusion protein (F) of PPRV (lacking N-terminal
fusion peptide, heptad repeat region 1, and C-terminal trans-
membrane domain) and the ectodomain of hemagglutinin
protein (H) of RPV (lacking cytoplasmic tail, transmem-
brane domain, and the stalk region) and analyzed the im-
munogenicity of the displayed proteins.
The recombinant viruses vBmGP64-F (ectodomain of
PPRV F protein fused to GP64) and vBmGP64-H (ectodo-
main of RPV H protein fused to GP64) contained the fusion
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cassettes under the control of the strong polyhedrin pro-
moter (Fig. 1). The recombinant BmNPVs were generated
by homologous recombination (Sriram et al., 1997). Al-
though the 5 upstream and 3 downstream regions of
AcMNPV polh present in the transfer vector pVL1393 are
not identical to the BmNPV polh flanking sequences, it was
still possible to generate recombinants at this locus and the
AcMNPV polh promoter was fully functional in BmN cells.
These recombinant viruses had the parental gp64, essential
for viral infectivity, and a second copy of the recombinant
gp64 gene (PPRV-F or RPV-H fusion) under the control of
the polyhedrin promoter. The presence of the gp64 fusion
cassette in the recombinant virus genomes was confirmed
by PCR amplification using appropriate primer combina-
tions. Unlike the prototype baculovirus AcMNPV where
different kinds of transfer vectors as well as improved
methods of generating recombinants are available, in
BmNPV the only method for generating recombinants is
homologous recombination and still relies on the cumber-
some method of occ phenotype for recombinant selection.
In the present work, we have improved the selection pro-
cedure to isolate BmNPV recombinants by introducing gfp
under the control of cytoplasmic actin A3 promoter within
the same transfer cassette but in orientation opposite to that
of polh and independent of polh transcription. The selection
of recombinants based on the positive GFP expression,
together with occ phenotype, made the process easier. The
recombinant viruses were purified through three rounds of
plaque isolation.
The titers of the recombinant viruses generated were
similar to the wild-type virus and stable in subsequent
passages. Such recombinant viruses synthesized substantive
amounts of the recombinant proteins and displayed them on
the infected cell surface.
Expression of GP64 fusion proteins
The expression of the recombinant proteins in the in-
fected BmN cells was confirmed by Western blot analysis
using anti-GP64, anti-PPRV-F, or anti-RPV-H antibodies
(Fig. 2). In the cells infected with vBmGP64-F, the expres-
sion of the 88-kDa band corresponding to the GP64-F fu-
sion protein, along with the parental GP64 (64 kDa) protein,
was detected using anti-GP64 antibody (Fig. 2A, lane 1).
The recombinant protein was further confirmed using anti-F
antibodies, which did not recognize the GP64 protein (Fig.
2A, lanes 4 and 5; compare with lanes 1 and 2). The
specificity of the antibodies was confirmed from the absence
of any immunoreactive protein bands in the uninfected
BmN cells (lanes 3 and 6).
Similarly, in the cells infected with vBmGP64-H, the
expression of the 98-kDa band corresponding to the
GP64-H fusion protein, along with the parental GP64 pro-
tein, was detected using anti-GP64 antibody (Fig. 2B, lane
1). Again, the authenticity of the recombinant protein was
confirmed using anti-H antibody, which did not recognize
the native GP64 protein (Fig. 2B, lanes 4 and 5; compare to
lanes 1 and 2). The specificity of the RPV-H antibodies was
also evident from the absence of any positive bands in the
uninfected BmN cells (Fig. 2B, lanes 3 and 6). The suc-
cessful expression of these recombinant proteins suggested
that fusion of heterologous proteins to GP64 did not affect
the expression of recombinant as well as the native GP64.
There was not much noticeable degradation of the expressed
recombinant proteins unlike in the case of GP64-GFP (Rah-
man and Gopinathan, 2003a), suggesting that stability of the
recombinant proteins depended on the nature of the fused
protein.
The GP64-F or GP64-H fusion proteins were also incor-
porated into the budded virus particles arising from the
recombinant virus infection (Fig. 3). The presence of both
native GP64 (64 kDa) as well as the GP64-F fusion protein
(88 kDa) was evident in the purified vBmGP64-F particles
(Fig. 3A, lane 1). The identity of the 88-kDa protein asso-
ciated with the purified budded virions as GP64-F fusion
was also confirmed using polyclonal anti-F (full-length pro-
tein) or anti-F (antibody raised against the F protein frag-
ment containing the neutralizing epitope, encompassing
heptad repeat 2 domain) antibodies (Fig. 3A, lanes 3 and 5,
respectively). These antibodies against F did not react with
the parental BmNPV budded virions (Fig. 3A, lanes 4 and 6).
The presence of both native GP64 as well as the GP64-H
fusion protein was evident in the purified vBmGP64-H
particles from the Western blots of the purified virus, probed
using anti-GP64 antibody (Fig. 3B, lane 1). The presence of
the 98-kDa protein associated with the purified budded
virions was also evident in Western blots probed with
anti-H antibody or monoclonal antibodies (A12A9 and
E2A3, respectively; Fig. 3B, lanes 3, 5, and 7). Clearly, the
signals due to monoclonal antibody reactions were much
weaker as compared to the polyclonal antibody against the
whole protein (see also later section shown in Fig. 5A). No
immunoreactive protein bands were detected in the wild-
type BmNPV using the same H-specific antibodies (Fig. 3B,
lanes 4, 6, and 8), whereas the parental GP64 was detected
using anti-GP64 antibody (lane 2).
Localization of the recombinant proteins in the infected
cells and tissues
The intention of generating the recombinant GP64 fusion
proteins was to display the expressed proteins on the host
cell surface. The localization of the expressed proteins in the
recombinant virus infected cells was established by immu-
nocytochemical staining (Fig. 4A). Both PPRV-F (Fig. 4A,
top row) and RPV-H (Fig. 4A, middle row) were located on
the cell membrane as well as cytoplasm of the infected cells.
The control panels with wild-type BmNPV-infected cells
did not show any fluorescence (bottom row). Excessive
levels of expression of these recombinant fusion proteins
(from the viral polh promoter) was presumably responsible
for their abundant presence in cytoplasm.
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We also analyzed the expression and localization of the
recombinant proteins in the fat body tissues of the infected
host larvae. Immunostaining of the fat bodies from
vBmGP64-F and vBmGP64-H infected B. mori larvae with
F and H antibodies showed that these proteins were local-
ized in the cell membrane as well as the cytoplasm of the
cells from the infected insects (Fig. 4B, top and middle
rows). To emphasize and clearly demarcate the localization
of the recombinant proteins, we have also shown the nuclear
staining of these cells with DAPI together with their overlay
on antibody staining. The control fat body samples from
wild-type BmNPV-infected larvae when stained with either
antibodies did not show fluorescence (Fig. 4B, bottom row).
The presence of the recombinant proteins in the infected
larvae was also confirmed by Western blot analysis of
hemocytes and fat body tissues using specific antibodies
(not shown). It is evident therefore that the infectivity of the
recombinant BmNPV to the host larvae is retained and the
expressed recombinant proteins are displayed on the cell
surface even in the insect larvae. Consequently it is possible
to use the B. mori larvae for large-scale production of
recombinant antigens in lieu of the cell-culture system.
Presentation of the recombinant proteins on the surface
of infected cells with correct display of the epitopes was
confirmed by immunofluorescence studies performed on
nonfixed, BmN cells. RPV-H protein was analyzed by poly-
clonal anti-H antibody as well as monoclonal antibodies
specific for H protein (A12A3 and E2A3) using FACS
following interaction with the secondary antibody conju-
gated to Cy3 (Fig. 5A). Both polyclonal and monoclonal
antibodies showed reaction with the displayed GP64 fusion
protein. The relative fluorescence intensity in interactions
with monoclonal antibodies was only about 25% of that of
polyclonal anti-H antibody and was in agreement with the
antibody staining of the budded virion proteins, shown in
Fig 3B. Since both the parental and the recombinant GP64
are present in recombinant virus-infected BmN cells, anti-
GP64 antibody reactions showed twice the intensity of flu-
orescence compared to the reaction with the displayed re-
combinant protein antibody. This difference could be due to
the differences in the affinities of the antibodies used, to the
expressed proteins. Alternatively it is possible that the pa-
rental GP64 and recombinant RPV-H were almost equally
distributed on the surface of infected cells if one assumes
equal affinity for these antibodies. Appropriate controls of
uninfected BmN cells or cells stained without primary or
secondary antibodies were also included in the analysis and
they did not show any fluorescence (marked BmN, control
1 and 2, respectively, in Fig. 5A).
The display of the GP64-F fusion protein on the surface
of vBmGP64-F-infected BmN cells was also analyzed sim-
ilarly by reaction with polyclonal anti-F and the domain-
specific polyclonal antibody. The surface of the infected
cells showed orange fluorescence on interaction with Cy3-
conjugated secondary antibody and the relative fluorescence
intensities were determined by FACS analysis (Fig. 5B).
Both antibodies gave almost equal intensity of fluorescence,
but once again it was about 50% of the fluorescence inten-
sity of staining with anti-GP64 antibody, as seen in the case
of the displayed GP64-H fusion protein. The controls (un-
infected BmN cells or infected cells stained without primary
or secondary antibody) lacked fluorescence.
The presentation of the displayed proteins on the surface
of budded virions was established by indirect ELISA (Figs.
6A and B). The recombinant budded virions, vBmGP64-F
and vBmGP64-H, were allowed to bind to the ELISA plates
through polyclonal antibodies to PPRV-F (against whole
protein or only the conserved B cell and Th epitopes con-
taining region on F) or polyclonal as well as monoclonal
antibodies to RPV-H (A12A9 or E2A3) coated onto the
wells. The viruses showed binding to the ELISA plates,
indicating that the expressed proteins were displayed on the
surface of virus particles. The wild-type BmNPV used as
controls did not show binding to any of the displayed
protein antibodies.
Immunogenicity in mice
The immunogenicity of H or F displayed on the recom-
binant BmNPV was examined in a mouse model. Adult
male BALB/c mice were immunized intraperitoneally
with the purified recombinant viruses, vBmGP64-F,
vBmGP64-H, and the wild-type BmNPV. The antibody titer
of the mice sera after immunization with the recombinant
budded virions was tested by ELISA, using either the re-
combinant secretory H protein (secH) as antigen for H or
the lysates of Vero cells infected with PPRV for F. High
antibody titers were achieved in both instances.
The specificity of these antibodies was also confirmed by
Western blots of total proteins from Vero cells infected with
Fig. 1. Generation of recombinant BmNPVs harboring the PPRV-F and RPV-H fused to GP64. Plasmid constructs harboring the gp64 ORF fused in-frame
with the ectodomains of PPRV-F or RPV-H at the BamHI site (shown details in the bottom) were mobilized into the polyhedrin-based transfer vector
pVL1393 in multiple steps (for details, see Materials and methods). The transfer vector also carried the reporter gene gfp under the control of actin A3
promoter (A3GFP) at the MCS, in orientation opposite to that of polh promoter. Recombinant vBmGP64-F and vBmGP64-H harboring these cassettes at the
viral polyhedrin locus under the control of the polh promoter were generated by transfection of BmN cells with the plasmid constructs, followed by infection
with the wild-type BmNPV. The presence of the insert at the appropriate locus in the recombinant viruses (selected based on occ gfp phenotype) was
confirmed by PCR. B, BamHI; E, EcoRI; K, KpnI; P, PstI; MCS, multiple cloning site; polh up, polh ds, and p polh refer to the upstream and downstream
regions of polyhedrin gene and polh promoter, respectively. The bottom shows the amino acid sequences and their corresponding numbers at the junctions
of the BmNPV GP64 and the fused foreign proteins. In-frame insertion of foreign gene at the BamHI site of GP64 resulted in duplication of D and P residues
(82 and 83) following the insertion and the introduction of an R residue in both instances. The amino acid residues (and their numbers) of the ectodomains
of PPRV-F (aa 265–486) and RPV-H (aa 295–609) are also indicated.
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RPV or PPRV (Fig. 7A). An 46-kDa protein correspond-
ing to F1 was detected in both RPV- and PPRV-infected cell
lysates (Fig. 7A, top) using antibodies raised against vB-
mGP64-F. Similarly, a72 kDa protein corresponding to H
was detected in both PPRV- and RPV-infected cell lysates
(Fig. 7A, bottom) using antiserum against vBmGP64-H.
The F and H proteins of PPRV and RPV are known to be
cross-reactive immunologically (Devireddy et al., 1999;
Khandelwal et al., 2003). Both sera did not show reactions
with uninfected Vero cell extract.
These antibodies, raised against the PPRV-F or RPV-H
proteins expressed on the BmNPV virus particles, exhibited
significant levels of virus neutralization activities (Fig. 7B,
showing the absence of cytopathic effect by inhibition of
cell fusion with PPRV treated with antibodies against re-
combinant BmNPV displaying fusion proteins; Table 1).
The antibody against the displayed F protein was equally
potent against PPRV and RPV in virus neutralization (Table
1). The virus neutralization titers of the displayed RPV-H
antibodies were lower than that of PPRV-F and it was also
less effective against PPRV. No neutralization activity
against RPV or PPRV was detected with preimmune serum
or serum from mice injected with BmNPV.
Since PPRV is known to possess hemagglutination ac-
tivity (Ramachandran et al., 1995), the hemagglutination
inhibition ability of these antisera was also tested (Table 1).
Both PPRV-F and RPV-H antisera raised against the
BmNPV-displayed antigens showed inhibition of hemag-
glutination activity of PPRV. The hemagglutination inhibi-
tion titer of PPRV-F antibodies was four times higher than
that against RPV-H. There was no inhibition by preimmune
serum or serum from mice infected with wild-type BmNPV.
The baculovirus display system permitted anchoring of
the recombinant fusion proteins on the surface of the in-
fected host cells or the budded virions. The presence of the
GP64 fusion did not alter the growth of the recombinant
viruses and high titer stocks of these viruses could be
achieved. Besides, the viral infectivity in cell cultures as
well as host larvae were also maintained.
The other eukaryotic viruses such as poliovirus (Burke et
al., 1988), rhinovirus (Resnick et al., 1995), and Sindbis
virus (London et al., 1992) or plant viruses such as tobacco
mosaic virus (Turpen et al., 1995) and cowpea mosaic virus
(Usha et al., 1993) previously proposed as vectors for dis-
play have been limited to the expression of short linear
peptides. The BmNPV-based system, on the other hand,
allowed the display of relatively large, full-length proteins.
The other advantage of the BmNPV system was the use of
purified virus particles as an immunogen, alleviating the
need for adjuvant because of the immunostimulatory effects
often associated with viral immunogens (Minev et al.,
1999). We have demonstrated here the ability to generate
antibodies by immunizing solely with purified recombinant
virions and such antisera had the potential to neutralize the
virus infectivity. Previously Lindley et al. (2000) had also
reported the antigenicity of virally displayed protein in
recombinant AcMNPV. The GP64 fusion of the antigens
allowed their display on the virus surface, making them
readily accessible for interactions with immune system
Fig. 2. Expression of recombinant proteins in infected cells. BmN cells
infected with the recombinant viruses vBmGP64-F or vBmGP64-H and
wild-type BmNPV (m.o.i. 10) were harvested at 72 hpi. The total cell
lysates were subjected to electrophoresis on 0.1% SDS–8% polyacryl-
amide gels, Western blotted, and probed using rabbit polyclonal anti-GP64
(both A and B, lanes 1, 2, and 3), anti-PPRV-F (A, lanes 4, 5, and 6), or
anti-RPV-H (B, lanes 4, 5, and 6) antibodies. The antibody reactions were
monitored by HRP-conjugated secondary antibodies and an ECL detection
kit. Lanes, as marked. Protein sizes are indicated with arrow.
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components. Further, the ability of the virus to display the
fusion protein in native conformation presumably with all
the necessary posttranslational modifications in the insect
host cells can augment the immunoreactivity of the dis-
played antigens.
The expression of the protein through the baculovirus
display system allows rapid generation of effective antigens
without the need for purifying the recombinant proteins.
Since the GP64 fusion proteins are expressed in native
conformation (as evidenced from the use of specific mono-
clonal antibodies), the immunoreactivity will be directed
toward the native antigens. The recombinant baculoviruses
also have a good biosafety profile and therefore vaccination
using recombinant baculoviruses should be a safe approach.
Materials and methods
Baculovirus and host cells
B. mori derived BmN cells were grown at 27°C in TC-
100 insect medium, supplemented with 10% fetal bovine
serum (FBS) and 50 g/ml gentamycin. BmNPV-BGL, a
local isolate of BmNPV (Palhan and Gopinathan, 1996),
was propagated in BmN cells. The budded virions were
purified by a series of high- and low-speed centrifugation
and banding on sucrose gradients (Palhan and Gopinathan,
1996) and were used for the generation of recombinant virus
or for the analysis of viral proteins and genomic DNA.
Vaccine strains of PPRV (Nig 75/1) and RPV (RBOK)
Fig. 3. Association of the recombinant GP64 fusion protein with virus particles. The budded viruses produced by infection of BmN cells with recombinant
viruses vBmGP64-F or vBmGP64-H and wild-type BmNPV (as a control) were purified by centrifugation on sucrose gradients. The virus particles were
solubilized in lysis buffer containing 2% SDS and subjected to electrophoresis on 0.1% SDS–8% polyacrylamide gels. The samples were Western blotted
and probed using anti-GP64 antibody (A and B, lanes 1 and 2), anti-F antibody (A, lanes 3 and 4), anti-HR2 antibody (A, lanes 5 and 6), anti-H antibody
(B, lanes 3 and 4), anti-H monoclonal antibodies (A12A9 and E2A3; B, lanes 5, 6, 7, and 8, respectively). Protein sizes are indicated with arrow.
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used for testing in vitro virus neutralization have been
described earlier (Renukaradhya et al., 2003). These viruses
were grown in Vero cells in Dulbecco’s modified Eagle’s
medium (MEM) supplemented with 5% FBS (Gibco-BRL).
The viral titers were determined by TCID50 performed ac-
cording to standard methods.
Transfer plasmids
The plasmid vector, pTZ18R-GP64, harboring BmNPV
full-length gp64 ORF was constructed earlier (Rahman and
Gopinathan, 2003a). The unique BamHI restriction site
within gp64 was utilized for in-frame fusion of ectodomains
of PPRV-F and RPV-H. The PPRV-F ectodomain without
the translational stop codon (encoded by nt 795 to nt 1458
encompassing amino acids 265–486) contained two B cell
epitopes, one of which is immunodominant and protective,
neutralizing measles virus and whose epitope sequences are
conserved across morbilliviruses, and the other, a T helper
epitope originally identified in MV fusion protein and con-
served in PPRV (Atabani et al., 1997; Partidos and Steward,
1990). The fragment was PCR amplified from the plasmid
construct pNSF5 (Seth and Shaila, 2001) using appropriate
oligonucleotide primers to make it in-frame with the target
gene gp64 (PCR forward primer, 5-CGGGATCCCGTCA-
CATATGTGGACACA-3, and reverse primer, 5-CG
GGATCCGCTACCCCTTTAACAGTC-3; the underlined
nucleotides generated a BamHI site). Similarly, RPV-H
ectodomain without the translational stop codon (encoded
by nt 882 to nt 1827 encompassing amino acids 294–609)
Fig. 4. Immunolocalization of expressed recombinant proteins in infected BmN cells (A) or fat body tissues of infected larvae (B). The intracellular
localization of the recombinant GP64 fusion protein in infected BmN cells was monitored by indirect immunofluorescence (A). BmN cells infected with the
recombinant viruses, vBmGP64-F (top row) or vBmGP64-H (middle row) and wild-type BmNPV (bottom row, as a control; m.o.i. 10) were pelleted after
48 hpi and washed with PBS. The localization of the recombinant proteins was detected by anti-F or anti-H antibody followed by reaction with the Cy3-tagged
secondary antibody (orange). The nuclei were stained with DAPI (blue). The samples were observed under fluorescence microscope. The four panels shown
from left to right are bright field, antibody staining, DAPI staining, and an overlay of the two. For immunolocalization of expressed recombinant proteins
in infected larval tissues, the fat body was dissected out from B. mori larvae infected with the recombinant viruses, vBmGP64-F (top row), vBmGP64-H
(middle row), or wild-type BmNPV (bottom row, as a control) after 4–5 days postinfection. The tissues were washed with PBS, and the localization of the
protein was detected using anti-F or anti-H antibody followed by reaction with the Cy3-tagged secondary antibody. The nuclei were stained with DAPI (blue).
The samples were observed under confocal microscope. The four panels shown from left to right are bright field, antibody staining, DAPI staining, and an
overlay of the two.
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was PCR amplified from the plasmid construct RB H3.4,
which contained the full-length cDNA for RPV-H (Naik
and Shaila, 1997), using appropriate oligonucleotide prim-
ers to make it in-frame with the gene gp64 (PCR forward
primer, 5-CGGGATCCCAAATTAGCTGCCCTCTGC-3,
and reverse primer, 5-CGGGATCCGCTTTCCCATTG-
CAAGTGAT-3; the underlined nucleotides generated a
BamHI site). These amplified ORFs were individually
cloned at the BamHI site of BmNPV gp64 to generate
pGP64PPRV-F and pGP64RPV-H, respectively. The fusion
cassettes were released by digestion with EcoRI and in-
serted into the EcoRI site of the baculovirus transfer vector
pVL1393-A3GFP, under the control of the AcMNPV polh
promoter. The transfer vector pVL1393-A3GFP was gener-
ated by inserting the reporter gene gfp under the control of
the B. mori cytoplasmic actin A3 promoter (Tamura et al.,
2000) between the NotI-BglII sites of the parental vector, in
orientation opposite to that of polh transcription, to facilitate
recombinant virus selection based on GFP expression. The
plasmids containing the PPRV-F or RPV-H domains and
the reporter gene gfp (under the actin promoter) within the
AcMNPV polh upstream and downstream flanking se-
quences as the transfer cassette, were used for homologous
recombination with BmNPV DNA.
Generation of recombinant virus
For generating the recombinant BmNPVs the transfer
plasmids pVL1393GP64-F and pVL1393GP64-H (5 g
DNA) were individually transfected into BmN cells (1 
106 cells) followed by BmNPV infection at 27°C (Sriram et
al., 1997). The recombinant viruses were selected based on
GFP expression with concomitant loss of polyhedral body
formation (gfp, occ phenotypes) and purified by three
rounds of plaque isolations. Individual recombinant viruses
were titered by plaque assay and high titer stocks of each
(108 PFU/ml) were used for infecting the cells and larvae.
Fig. 4 (continued)
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SDS–PAGE and Western blots
The budded virus (BV) samples for immunoblot analysis
were concentrated from 30 ml infected cell-culture super-
natants by ultracentrifugation (100,000 g, 90 min at 4°C).
The viral pellet was washed and solubilized in SDS–PAGE
sample buffer containing -mercaptoethanol, boiled for 5
min, and 1/20th of the sample was used for electrophoresis.
The proteins were transferred on to PVDF membranes (Am-
ersham) using semidry electric transfer and probed using
rabbit polyclonal anti-GP64, anti-F, or anti-H antisera or
monoclonal anti-H antibodies. Polyclonal antibodies to
BmNPVGP64 were raised in both rabbit and mice, using the
bacterially expressed purified protein (Rahman and Gopi-
nathan, 2003b). Generation of polyclonal anti-H (RPV) and
anti-F (PPRV) antibodies has been described earlier (De-
vireddy et al., 1998). They were made using proteins puri-
fied from PPRV-infected cells. A fragment of PPRV F
protein having the conserved B cell epitopes, as well as T
helper epitopes, was expressed in Escherichia coli as His-
tag fusion and used for making antibodies in rabbit after Ni
affinity purification (Seth and Shaila, 2001). Monoclonal
antibodies (A12A9 and E2A3) were generated against se-
creted hemagglutinin protein (secH) of RPV expressed by
recombinant AcMNPV (Renukaradhya et al., 2002). Anti-
body reactions were detected using anti-rabbit IgG or anti-
mouse IgG as the case may be, conjugated to horseradish
peroxidase followed by ECL chemiluminescence kit (Am-
ersham Pharmacia Biotech).
To analyze the expression of GP64PPRV-F and
GP64RPV-H fusion proteins in the infected cells, BmN
cells infected with the recombinant viruses (either
vBmGP64-F or vBmGP64-H; m.o.i. 10) were harvested at
72 hpi, washed with phosphate-buffered saline (PBS), and
lysed using lysis buffer (50 mM Tris–HCl, pH 8.0, 150 mM
NaCl, 1% NP-40, 10mM PMSF). The samples were sub-
jected to electrophoresis on 0.1% SDS–8% polyacrylamide
gels and analyzed by Western blots.
Immunofluorescence microscopy
BmN cells grown in 35-mm culture dishes were infected
with the wild-type or recombinant BmNPV (m.o.i. 10). At
48 hpi, the cells were harvested, washed twice with PBS,
and fixed in 4% paraformaldehyde for 15 min. The fixed
cells were permeabilized by 0.1% Triton X-100, blocked in
1% BSA and 2.5% normal goat serum (NGS), and reacted
with anti-F or anti-H polyclonal antibody (1:100). The an-
tibody reaction was detected using the secondary antibody
(goat anti-rabbit IgG conjugated to Cy3, Sigma Chemical
Co., USA) and observed under fluorescence microscope
(Leica), after mounting on glass slides, with 50% glycerol.
Detection of recombinant protein on the virus particle by
ELISA
The polyclonal or monoclonal antibodies against the
displayed proteins coated on 96-well microtiter plates
(1:500 dilution in PBS, at 4°C overnight) were incubated
with recombinant or control virus preparations (purified
budded virus samples, at protein concentrations starting
from 100 ng as the highest and serially diluted by a factor of
2) for 1 h at 37°C to allow binding, followed by washing
(0.1% Tween 20 containing PBS). The presence of bound
recombinant BmNPV virus particles was detected using
rabbit or mouse polyclonal anti-GP64 antibody (1:250 in
PBS and incubation for 1 h at 37°C). Antibody reactions
were detected by reactions with the corresponding anti IgGs
Fig. 5. FACS analysis of recombinant virus infected, nonfixed BmN cells.
BmN cells (1 106) were infected (m.o.i. 10) with the recombinant viruses
and harvested after 48 hpi. Three independent infections were made for
each virus and stained separately for the displayed protein (F or H specific
polyclonal or monoclonal antibodies and anti-rabbit or anti-mouse Cy3
conjugated secondary antibodies). Staining for GP64 expression on the
virus-infected cells was also included as a positive control. A total of
10,000 events were measured for FACS analysis. Uninfected BmN cells
and infected cells stained without primary (control 1) or secondary anti-
body (control 2) served as negative control. On the y-axis the mean
intensity of fluorescence for infected BmN cells, expressed as the median
of fluorescence of three independent infections, is shown. A, vBmGP64-H
infection; B, vBmGP64-F infection.
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conjugated to horseradish peroxidase (1:2500 in PBS) for
1 h at 37°C, followed by reaction with o-phenylene diamine
dihydrochloride as substrate (A, 490 nm).
Cell-surface immunofluorescence
The proper display of the antigenic domains of the re-
combinant viral antigens on the host cell surface was ex-
amined by using cells that were not fixed with chemicals.
BmN cells, infected with recombinant viruses vBmGP64-F
or vBmGP64-H (m.o.i. 10), were harvested at 48 hpi and
distributed into 2 ml of TC-100 medium supplemented with
10% FCS. These unfixed cells were incubated individually
with PPRV-F- and RPV-H-specific polyclonal or monoclo-
nal antibodies (1:100 dilution), for 1 h at room temperature
and washed three times with complete TC-100 medium.
The cells were incubated afterwards with anti-rabbit or
anti-mouse IgG conjugated to Cy3 (1:200 dilutions) for 1 h.
After extensive washing, the cells were observed under a
fluorescence microscope (Leica). For flow cytometry, the
stained cells were analyzed in a FACS scan flow cytometer
(Becton–Dickinson, USA).
Fig. 6. Detection of recombinant proteins on virus particles by ELISA. The recombinant or wild-type budded viruses were purified by sucrose gradient
centrifugation, serially diluted twofold from an initial concentration of 5 g/ml (100 ng protein per well), and added to ELISA plates that had been
precoated with polyclonal or monoclonal anti-F or anti-H antibodies (diluted 1:500). The presence of bound virus particles was detected using rabbit or mouse
polyclonal anti-GP64 antibodies (1:250, in PBS) followed by anti-rabbit or anti-mouse IgG-HRP conjugate. Values on the y-axis show A490-nm readings
and numbers on the x-axis correspond to reciprocal dilutions of virus samples. (A) Budded virions of vBmGP64-F analyzed with anti-F (full length) or
anti-HR2 (HR2 domain of F) polyclonal antibodies. A control showing the absence of binding by wild-type BmNPV is also included. (B) Budded virions
of vBmGP64-H analyzed with anti-H polyclonal antibody or A12A9 monoclonal antibody against H. A control of BmNPV, showing no binding is also
included.
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Infection of B. mori larvae
B. mori larvae (strain NB4D2) in the first day of fifth
instar were infected with 40 l of wild-type or recombinant
virus (108 PFU/ml) by direct injection into hemocoel at the
third abdominal spiracle. After 4–5 days of infection the fat
body tissues were dissected out from the larvae, washed
with PBS, and stored at 70°C. Immunolocalization of the
recombinant proteins in the infected fat body tissues was
done as in the case of the infected BmN cells. The tissues
were observed under a confocal microscope (Leica), using
green laser light at 545 nm for excitation and a 560 nm for
emission.
Immunogenicity in mice
Two groups, each containing three male BALB/c mice
(90 days old), were immunized intraperitoneally with re-
combinant or wild-type budded viruses purified from the
infected cell supernatant (300 g protein) without any ad-
juvant. One animal from each group served as unimmunized
control. Two boosters with half of the protein amount were
given on days 14 and 21 after the first injection. Mice were
bled retroorbitally and the serum was tested for the presence
of specific antibodies to PPRV-F or RPV-H by ELISA.
Virus neutralization test (VNT)
VNT was performed according to Barrett et al. (1989).
Briefly, the vaccine strain of RPV (RBOK strain) and the
vaccine strain of PPRV (Nig 75/1) were grown in Vero
cells. The individual viruses (100 TCID50 units) were incu-
bated at 37°C for 1 h with dilutions of the test or control sera
(heat inactivated at 56°C for 30 min) and then added to Vero
cells growing in a flat, bottom 96-well tissue culture plate.
Cells were observed microscopically for cytopathic effect
Fig. 7. (A) Detection of F and H proteins in the infected Vero cells using antibodies raised against the virally displayed recombinant proteins. The cell lysates
from Vero cells infected with PPRV or RPV at 72 hpi (after observing 70–80% CPE) were subjected to electrophoresis on 0.1% SDS–8% polyacrylamide
gels. The Western blots were probed using GP64-F (top) or GP64-H (bottom) antisera from mice immunized with the corresponding recombinant viruses.
The antibody reactions were monitored by HRP-conjugated secondary antibodies and an ECL detection kit. Lanes and protein sizes, as marked. (B) Fusion
inhibition by antibody (GP64-F or GP64-H) in infected Vero cells. a, uninfected control Vero cells; b, untreated infected cells showing characteristic syncytia
formation; c, cells infected with the antibody treated virus.
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(CPE; lysis and fusion of cells) from 3 days onward and the
ability of the test sera to neutralize virus infectivity was
determined after 5–7 days. To observe the CPE, cells were
washed in PBS, fixed with 95% ethanol and 5% acetone at
20°C for 20 min, and stained with Giemsa or 0.1% crystal
violet. The reciprocal of the highest dilution of the test
serum at which the CPE was 50% or less than that of the
virus infected control well was taken as the virus neutral-
ization titer.
Hemagglutination and hemagglutination inhibition assays
Hemagglutination assays were performed according to
Rosanff (1961). For hemagglutination inhibition (HI) assay,
test and control sera were diluted in steps of 1:5 fold in PBS
to a final volume of 25 l in a U-bottom 96-well plate.
PPRV antigen (PPRV Nig 75/1 infected cell extract, 25 l
corresponding to 4 HA units) was added to the wells and
then the standard HI assay procedure was followed (Norrby,
1962).
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